Bluejay Diagnostics (BJDX) Depreciation & Amortization (CF) (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Depreciation & Amortization (CF) of $27763.0 for Q1 2026, up 1.27% sequentially from $27415.0 in Q4 2025, and up 50.88% YoY from $18401.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $27763.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 50.88% year-over-year to $27763.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83544.0 (up 12.43% YoY) and the FY2025 annual result came in at $74182.0, down 1.9% from the prior year.
- Depreciation & Amortization (CF) grew to $27763.0 in Q1 2026 per BJDX's latest filing, from $27415.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $253175.0 in Q2 2023 and troughed at $10624.0 in Q3 2025.
- A 5-year average of $53403.1 and a median of $27415.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) jumped 501.02% in 2023, then tumbled 93.02% in 2024.
- Over 5 years, Depreciation & Amortization (CF) stood at $30682.0 in 2022, then declined by 27.18% to $22342.0 in 2023, then slipped by 11.49% to $19775.0 in 2024, then surged by 38.63% to $27415.0 in 2025, then climbed by 1.27% to $27763.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $27763.0, $27415.0, and $10624.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28,193.00 |
| Jun 30, 2026 | 28,193.00 |
| Mar 31, 2026 | 27,763.00 |
| Mar 31, 2026 | 27,763.00 |
| Dec 31, 2025 | 27,415.00 |
| Dec 31, 2025 | 27,415.00 |
| Sep 30, 2025 | 10,624.00 |
| Sep 30, 2025 | 10,624.00 |
| Jun 30, 2025 | 17,742.00 |
| Jun 30, 2025 | 17,742.00 |
| Mar 31, 2025 | 18,401.00 |
| Mar 31, 2025 | 18,401.00 |
| Dec 31, 2024 | 19,775.00 |
| Dec 31, 2024 | 19,775.00 |
| Sep 30, 2024 | 17,665.00 |
| Sep 30, 2024 | 17,665.00 |
| Jun 30, 2024 | 18,464.00 |
| Jun 30, 2024 | 18,464.00 |
| Mar 31, 2024 | 19,714.00 |
| Mar 31, 2024 | 19,714.00 |